I hate to be the only one getting responses but I did get one. I did send my email out a lot earlier though. The answer was that it was an error in the August PR and instead of stating data in Q3 it should have said Q4. The delay in getting the data is because the rest of the patients, should be around 6 of them, are being treated with product using the new manufacturing process. So while they were enrolled last year they waited to dose them until they had the FDA approval to use the new process.
I still don't think the error was acceptable and I would honestly be ok at this point with them not giving any timelines and just releasing it when it is ready.
I have more information on other matters that I will work up a post on.
News 
Market Data 
Discover 
